AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank64
5Y CAGR-9.9%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

5Y CAGR
-9.9%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202513.88%
202421.21%
20231.60%
2022-10.83%
202111.59%
202023.35%
201911.13%
201812.49%
201710.82%
201618.55%